Radioiodine-induced autoimmune hyperthyroidism: Case report

Endocrinologist

Volumn 18, Issue 3, 2008, Pages 124-125

  Bulzico, Daniel Alves ^a,b   Cabizuca, Carolina Alves ^a   De Mello, Rossana Corbo Ramalho ^b   Vaisman, Mario ^a  

^a Department of Endocrinology ^*  (Brazil)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

131I therapy; Autoimmune hyperthyroidism; Nodular toxic goiter

Indexed keywords

IODINE 131; PROPYLTHIOURACIL; RADIOACTIVE IODINE; THIONAMIDE; THYROTROPIN; THYROXINE;

ADULT; ARTICLE; ASPIRATION BIOPSY; AUTOIMMUNE DISEASE; CASE REPORT; CLINICAL FEATURE; CONJUNCTIVAL HYPEREMIA; DISEASE COURSE; DRUG UPTAKE; ECHOGRAPHY; EXOPHTHALMOS; EYE DISEASE; FATIGUE; FEMALE; GOITER; HUMAN; HYPERTHYROIDISM; IODINE 131 UPTAKE TEST; LABORATORY TEST; PALPATION; PHYSICAL EXAMINATION; SYMPTOM; TACHYCARDIA; THYROID NODULE; THYROID SCINTISCANNING; THYROTOXICOSIS; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL; TREATMENT DURATION; TREATMENT OUTCOME; WEIGHT REDUCTION;

EID: 67650733817     PISSN: 10512144     EISSN: None     Source Type: Journal    
DOI: 10.1097/TEN.0b013e318175d1ef     Document Type: Article

References (4)

1. Huysmans Hermus RM, Edelbroek MA, et al. Autoimmune hyperthyroidism occurring late after radioiodine treatment for volume reduction of large multinodular goiters. Thyroid. 1997;7:535-539.
2. Nygaard B, Faber J, Veje A, et al. Transition of nodular toxic goiter to autoimmune hyperthyroidism triggered by 131I therapy. Thyroid. 1999;9: 477-481.
3. Nygaard B, Knudsen J, Hegedus L, et al. Thyrotropin receptor antibodies and Grave's disease, a side-effect of 131I treatment in patients with nontoxic goiter. J Clin Endocrinol Metab. 1997;82:2926-2930.
4. Gallegos E, Meier DA, Garcia M. Grave's disease triggered by autoinfarction of an autonomously functioning thyroid adenoma. J Nucl Med. 1997;38:260-262.